Supernus Pharmaceuticals Inc (LTS:0LB2)
$ 31 -2.63 (-7.82%) Market Cap: 1.71 Bil Enterprise Value: 1.41 Bil PE Ratio: 349.21 PB Ratio: 1.79 GF Score: 82/100

Supernus Pharmaceuticals Inc (LTS:0LB2) Transcripts

  • 1